Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.50
Bid: 54.00
Ask: 57.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.556%)
Open: 55.50
High: 55.50
Low: 55.50
Prev. Close: 55.50
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on the Offer of Subscription

6 Mar 2020 14:56

RNS Number : 3282F
Baronsmead Second Venture Trust PLC
06 March 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

Baronsmead Second Venture Trust plc

6 March 2020

Update on the Offer for Subscription

The Board of Baronsmead Second Venture Trust plc (the "Company") announced on 4 October 2019 that it had published a Prospectus in conjunction with Baronsmead Venture Trust plc in relation to an offer for subscription to each raise up to £20 million (before costs) with an over-allotment facility to each raise up to a further £5 million (the "Offer").

On 27 February 2020 the Company carried out a third allotment of shares under the Offer, issuing 2,318,288 new ordinary shares of 10 pence each in the Company ("New Shares"). Subsequently, at the annual general meeting of the Company held on 27 February 2020, shareholders approved the payment of a final dividend of 3.5 pence per share (the "Final Dividend"). However, the net asset value as at 31 January 2020 did not take account of the Final Dividend and accordingly the net asset value used to calculate the issue price which the New Shares were issued at was overstated by the amount of the Final Dividend.

On the basis of the adjusted net asset value the Company has issued an additional 101,155 New Shares resulting in 2,419,443 New Shares being issued in the third allotment under the Offer at an issue price of 82.50 pence.

Applications have been made for the additional New Shares to be issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the additional New Shares to be issued pursuant to the Offer at 8.00 a.m. on 11 March 2020.

Share certificates and tax certificates in respect of the original issue of New Shares have not yet been issued. It is expected that share certificates and tax certificates showing the aggregate number of New Shares issued will be sent to the relevant Shareholders within 10 business days of the date of the allotment of the additional New Shares.

Total voting rights

Each Ordinary Share has one voting right. Following the issue of additional New Shares pursuant to the Offer, the Company will have 268,014,594 Ordinary Shares in issue (of which 22,750,063 Ordinary Shares are held in treasury). The total number of voting rights in the Company will therefore be 245,264,531 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Further information

For further information please contact.

Baronsmead VCT Investor Relations

020 3875 9862

baronsmeadvcts@greshamhouse.com

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEZQLFBBXLEBBZ
Date   Source Headline
6th Jun 20235:30 pmRNSNet Asset Value(s)
12th May 20237:00 amRNSCompliance with the Market Abuse Regulation
5th May 20235:30 pmRNSNet Asset Value(s)
4th May 20231:00 pmRNSNet Asset Value(s)
2nd May 202312:52 pmRNSTotal Voting Rights
5th Apr 20236:30 pmRNSTransaction in Own Shares
3rd Apr 20235:26 pmRNSTotal Voting Rights
3rd Apr 20233:49 pmRNSAllotment of Shares
3rd Apr 202311:11 amRNSTotal Voting Rights
30th Mar 202312:00 pmRNSNet Asset Value(s)
27th Mar 20235:23 pmRNSUpdate on Fundraising
14th Mar 20234:28 pmRNSAllotment of Shares
13th Mar 20235:44 pmRNSDirector/PDMR Shareholding
13th Mar 20235:43 pmRNSDirector/PDMR Shareholding
9th Mar 20236:25 pmRNSTransaction in Own Shares
9th Mar 20233:17 pmRNSUpdate on Fundraising
6th Mar 20234:45 pmRNSNet Asset Value(s)
1st Mar 20232:23 pmRNSTotal Voting Rights
24th Feb 20235:20 pmRNSUpdate on Fundraising
17th Feb 20236:16 pmRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSTransaction in Own Shares
6th Feb 20235:00 pmRNSNet Asset Value(s)
1st Feb 20233:58 pmRNSDirector/PDMR Shareholding
1st Feb 20233:56 pmRNSResult of AGM
30th Jan 20235:38 pmRNSDirector/PDMR Shareholding
30th Jan 20235:36 pmRNSDirector/PDMR Shareholding
30th Jan 20233:05 pmRNSAllotment of Shares
27th Jan 202311:30 amRNSNet Asset Value(s)
3rd Jan 20234:50 pmRNSTotal Voting Rights
29th Dec 20224:56 pmRNSTransaction in Own Shares
16th Dec 202212:47 pmRNSPublication of a Prospectus
12th Dec 20224:45 pmRNSTransaction in Own Shares
6th Dec 20225:30 pmRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSAnnual Financial Report
7th Nov 202211:30 amRNSNet Asset Value(s)
1st Nov 202211:21 amRNSTotal Voting Rights
14th Oct 20226:16 pmRNSTransaction in Own Shares- Correction
14th Oct 20224:45 pmRNSNet Asset Value(s)
4th Oct 202211:57 amRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSTotal Voting Rights
29th Sep 20226:32 pmRNSTransaction in Own Shares
13th Sep 20226:03 pmRNSTransaction in Own Shares
6th Sep 20225:45 pmRNSNet Asset Value(s)
1st Sep 20225:49 pmRNSTotal Voting Rights
16th Aug 20224:57 pmRNSTransaction in Own Shares
12th Aug 202211:44 amRNSIntention to Fundraise
4th Aug 20226:00 pmRNSNet Asset Value(s)
20th Jul 20227:00 amRNSNet Asset Value(s)
1st Jul 20223:44 pmRNSTotal Voting Rights
15th Jun 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.